Singapore markets close in 3 hours 17 minutes

AXIM Biotechnologies, Inc. (AXIM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0115-0.0007 (-6.15%)
At close: 03:30PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
39.518
39.518
8.875
60.46
0
Cost of revenue
-
-
-
-
0
Gross profit
-
-
-
-
0
Operating expenses
Research development
125.496
125.496
153.697
284.869
426.708
Selling general and administrative
2,238
2,238
4,082
5,668
4,506
Total operating expenses
2,790
2,790
4,662
7,789
4,833
Operating income or loss
-2,751
-2,751
-4,653
-7,729
-4,833
Interest expense
1,205
1,205
1,876
485.825
320.813
Total other income/expenses net
-4,104
-4,104
285.983
-7,553
-1,137
Income before tax
-8,060
-8,060
-6,243
-16,024
-6,291
Income tax expense
0
0
0
0
0
Income from continuing operations
-8,060
-8,060
-6,243
-16,024
-6,291
Net income
-8,060
-8,060
-6,243
-16,032
-6,410
Net income available to common shareholders
-8,060
-8,060
-6,243
-16,032
-6,410
Basic EPS
-0.03
-
-0.04
-0.12
-0.06
Diluted EPS
-0.03
-
-0.04
-0.12
-0.06
Basic average shares
214,973
-
165,468
131,540
110,386
Diluted average shares
214,973
-
165,468
131,540
110,386